Dfpg Investments, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History
Dfpg Investments, LLC
- $1.29 Billion
- Q4 2023
A detailed history of Dfpg Investments, LLC transactions in Eiger Bio Pharmaceuticals, Inc. stock. As of the latest transaction made, Dfpg Investments, LLC holds 32,430 shares of EIGR stock, worth $410,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,430
Previous 32,430
-0.0%
Holding current value
$410,239
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EIGR
# of Institutions
6Shares Held
748KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY345KShares$4.36 Million0.64% of portfolio
-
Act Capital Management, LLC Wayne, PA235KShares$2.97 Million2.44% of portfolio
-
Drw Securities, L.L.C. Chicago, IL120KShares$1.52 Million0.02% of portfolio
-
Zeke Capital Advisors, LLC Berwyn, PA13KShares$164,4500.0% of portfolio
-
American Portfolios Advisors Holbrook, NY2.25KShares$28,4620.0% of portfolio
About Eiger BioPharmaceuticals, Inc.
- Ticker EIGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,966,800
- Market Cap $556M
- Description
- Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...